Immunoresistant to immunosensitive - Histotripsy's unique potential to overcome resistance.

Saved in:
Bibliographic Details
Title: Immunoresistant to immunosensitive - Histotripsy's unique potential to overcome resistance.
Authors: Kim S; Cooper Medical School of Rowan University, Camden, NJ 08103, USA. Electronic address: kimsar32@rowan.edu., Majumdar A; Cooper Medical School of Rowan University, Camden, NJ 08103, USA. Electronic address: majumd52@rowan.edu., Waters JP; Cooper Medical School, UC Davis Medical Center, Sacramento, California, 95817, USA. Electronic address: waters72@rowan.edu., Topper GV; Cooper University Hospital, Division of Surgery, Camden, NJ 08103, USA. Electronic address: topper-gena@cooperhealth.edu., Ghanem Y; Cooper University Hospital, Division of Surgery, Camden, NJ 08103, USA. Electronic address: ghanem-yazilkhalilmo@cooperhealth.edu., Elbezanti W; Cooper University Hospital, Division of Surgery, Camden, NJ 08103, USA. Electronic address: weam-elbezanti@cooperhealth.edu., Song S; Cooper University Hospital, Division of Surgery, Camden, NJ 08103, USA. Electronic address: song-shumei@cooperhealth.edu., Hong YK; Cooper University Hospital, Division of Surgery, Camden, NJ 08103, USA. Electronic address: hong-young@cooperhealth.edu.
Source: Critical reviews in oncology/hematology [Crit Rev Oncol Hematol] 2026 Jan; Vol. 217, pp. 105054. Date of Electronic Publication: 2025 Nov 27.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Netherlands NLM ID: 8916049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0461 (Electronic) Linking ISSN: 10408428 NLM ISO Abbreviation: Crit Rev Oncol Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0461
DOI:10.1016/j.critrevonc.2025.105054